FGFR GENE ALTERATIONS
Clinical trials for FGFR GENE ALTERATIONS explained in plain language.
Never miss a new study
Get alerted when new FGFR GENE ALTERATIONS trials appear
Sign up with your email to follow new studies for FGFR GENE ALTERATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets genetic drivers in tough-to-treat cancers
Disease control Recruiting nowThis is the first study in people testing an experimental pill called TYRA-430. It aims to find a safe dose and see if it can help control advanced liver cancer and other solid tumors that have specific genetic changes in the FGF/FGFR pathway. The study will enroll about 100 adul…
Matched conditions: FGFR GENE ALTERATIONS
Phase: PHASE1 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New drug targets Cancer's genetic weakness in patients out of options
Disease control Recruiting nowThis trial is testing an experimental drug called E7090 for people with advanced or returning solid tumors that have specific changes in a gene called FGFR. It is for patients whose cancer has stopped responding to standard treatments or for whom no standard treatments are availa…
Matched conditions: FGFR GENE ALTERATIONS
Phase: PHASE2 • Sponsor: National Cancer Center, Japan • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Targeted pill trial aims to wipe out early bladder tumors
Disease control Recruiting nowThis study is testing an oral medication called TYRA-300 for adults with early-stage, non-muscle-invasive bladder cancer that has a specific genetic change (FGFR3). The goal is to see if the pill can completely eliminate visible tumors left in the bladder after a biopsy. Research…
Matched conditions: FGFR GENE ALTERATIONS
Phase: PHASE2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC